Patent · US Expired

Resilient transdermal drug delivery device

US5006342A · kind A · utility

150Cited by
26References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 10, 1989
Grant dateApr 9, 1991
Priority date
Expiry dateFeb 10, 2009

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/445
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A solid state, resilient laminated composite for administering a drug transdermally consisting of a multiplicity of spaced structural laminas of a resilient elastomer, one of which forms the top of the composite, a viscoelastic hydrophobic polymer lamina containing propylene glycol monolaurate interposed between each structural lamina and a pressure-sensitive adhesive lamina that provides the basal surface of the composite and consists of a blend of a pressure-sensitive adhesive, drug and propylene glycol monolaurate.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.